SINGULAIR MRK 711 (Singulair 4 mg)
Generic Name: montelukast
Pill imprint SINGULAIR MRK 711 has been identified as Singulair 4 mg.
Singulair is used in the treatment of allergic rhinitis; bronchospasm prophylaxis; asthma, maintenance; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Singulair 4 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- SINGULAIR MRK 711
- 4 mg
- 11.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Leukotriene modifiers
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Merck & Company Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
hydroxypropyl cellulose (type h)
ferric oxide red
|NDC Code||Manufacturer / Repackager|
|54868-4630||Physicians Total Care Inc (repackager)|
|55289-0989||PDRX Pharmaceuticals Inc (repackager)|
|49999-0952||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Singulair (montelukast)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.